Lizzie Dorfman is a senior technical program manager for Google AI, overseeing a portfolio of projects focused on combining deep learning with genomics to develop new capabilities and tools that will empower researchers, accelerate discoveries, and ultimately improve people’s lives. Before joining Google, Dorfman worked for Verily Life Sciences, where she oversaw molecular data analysis, and was an early employee of 23andMe, where she launched the world’s largest genetic study of Parkinson’s disease. A policy specialist for Google from 2003 to 2008, she received her PhD from the University of Washington Institute for Public Health Genetics for her research in obstetric pharmacology and placental drug transport.
Previously
Digital systems make it possible to identify patterns and trends in global and domestic health that foster better clinical decision-making and ultimately improve outcomes. Sim...
Once inventions work their way into widespread use –- the Internet and the cell phone, the X-ray machine and the CT scanner –- we stop thinking about them as novelties, and st...
Artificial intelligence is an increasingly valuable coin of the realm in medicine. It is already playing a role in disease diagnosis, drug development, surgery, maternal and c...
Artificial intelligence, which recognizes patterns in data, images, and sound, is poised to move from the laboratory to the clinic and may upend health delivery in the process...